3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
156
Active not recruiting
81
Recruiting
75
Terminated
68
Unknown
33
Withdrawn
16
Not yet recruiting
13
Suspended
1
No longer available
1
Sponsor Class
NIH
2
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Advanced Renal Cell Carcinoma
1
Interventions
Specimen Handling
12
Magnetic Resonance Spectroscopy
10
Cyclophosphamide
10
Cisplatin
7
Bevacizumab
7
pembrolizumab
6
Radiosurgery
6
Oxaliplatin
5
Nivolumab
5
Irinotecan
5
Fluorouracil
5
Everolimus
5
Capecitabine
5
Biopsy
5
venetoclax
4
fludarabine
4
S 1 (combination)
4
Prednisone
4
Leucovorin
4
Gemcitabine
4
Etoposide
4
Drug Therapy
4
Doxorubicin
4
Azacitidine
4
fludarabine phosphate
3
Vincristine
3
Taxes
3
Tacrolimus
3
Surveys and Questionnaires
3
Surgical Procedures, Operative
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Suspended
×
OTHER
×
Ipilimumab
×
Clear all
NCT05928806
2026-02-11
ARCITECT
Hoosier Cancer Research Network
Phase 2
Suspended
120 enrolled